Abstract
In Brazil, cardiovascular diseases account for approximately 25% of all deaths annually, half of them due to acute coronary syndromes, especially acute myocardial infarction (AMI) and its immediate and mid-term consequences. They account for approximately 50% of the costs of our health care system and even so, access to elective therapies such as primary angioplasty and fibrinolytic thera…